Zobrazeno 1 - 10 of 122 pro vyhledávání: '"F Ranchon"'
1
Akademický článek
Sodium thiosulfate protects from renal impairement following hyperthermic intraperitoneal chemotherapy (HIPEC) with Cisplatin
Autor: N. Laplace, V. Kepenekian, A. Friggeri, O. Vassal, F. Ranchon, C. Rioufol, W. Gertych, L. Villeneuve, O. Glehen, N. Bakrin
Publikováno v: International Journal of Hyperthermia, Vol 37, Iss 1, Pp 897-902 (2020)
Background Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) has been shown to provide benefits in the management of peritoneal metastasis. Cisplatin (CDDP) is one of the most frequently used drugs for peritoneal i
Externí odkaz: https://doaj.org/article/5bff60cadcc049329fcc30916473dc6b
Zobrazit plný text záznamu
2
Akademický článek
Characteristics of pharmacist’s interventions triggered by prescribing errors related to computerised physician order entry in French hospitals: a cross-sectional observational study
Autor: Céline Vermorel, A. Lescoat, Pierrick Bedouch, M.O. Duzanski, L. Bourguignon, N. Thiriat, Bruno Charpiat, Ornella Conort, Jean-Luc Bosson, R. Contreras, S. Roche, A. Fouquet, Manon Videau, S. Abkhtaoui-Couriat, B. Allard-Latour, C. Andrieu, X. Armoiry, E. Armoiry, D. Attivi, L. Audibert, A. Barbet, M. Bascoulergue, C. Basselin, F. Baud, P. Bedouch, M. Belhout, S. Benhaoua, J. Beny, S. Berthet, J. Berthou, D. Bichard, A.C. Blandin, E. Blondel, S. Bonn Loue, A. Bonvin, F. Bouchand, P. Bouniot, M. Bourdelin, C. Bouret, C. Bourne, M. Bouteille, J. Burdin, C. Bureau, M. Burgin, M. Buyse, E. Cabaret, D. Cabelguenne, D. Carli, I. Carpentier, E. Chambrey, S. Chantel, N. Charhon, B. Charpiat, M. Chaumont, K. Civiletti, B. Clerc, M. Cleve, R. Colomb, C. Combe, O. Conort, S. Crepin, M. Creusat-Aube, A. Cuoq, C. Decourcelle, T. Delanoy, C. Derharoutunian, A. Deronze, M. Desseignet, S. Diallo, L. Dietrich, A. Dory, J. Dos-Reis, N. Duarte, L. Escofier, F. Fabre, S. Fare, J. Fillon, A. Fonteneau, A. Gadot, H. Galtier, I. Garreau, C. Gerard, R. Gervais, O. Gloulou, I. GraguebChatti, A. Grass, I. Gremeau, P.Y. Grosse, C. Guenaire, F. Guerin, A. Guillermet, S. Hannou, A. Henry, G. Herbin, N. Herment, A. JanolyDumenil, C. Jarre, L. Jovenaux, M. Juste, A.S. Kaczmarek, W. KiniMatondo, H. Labrosse, C. Laillier, E. Lamarre, J. Lamoureux, M. Laurent, A. Le Bris, M. Le Duff, R. Lecointre, J. Lecompte, M. Lefebvre, A.L. Lepetit, H. Lepont-Gilardi, J.P. Levillain, G. Liguori, C. Lohier, C. Lupo, J. Machon, K. Maes, G. Magerand, K. Mangerel, S. Martelet, D. Matanza, V. Mermet, C. Mouchoux, Y. Nivoix, A. Orly, E. Orng, A. Oufella, I. Paillole, D. Pallot, A. Papon, L. Parnet, M. Paysant, E. Perrier-Cornet, S. Perrin, D. Peynaud, B.N. Pham, D. Piney, A. Pohyer, C. Porot, J. Pouzoulet, L. Poy, E. Prevost, E. Prunier, F. Ranchon, M. Rave, C. Remonnay, M. Remy, M. Rhalimi, C. Rioufol, A. Robelet, F.X. Rose, R. Roubille, A. Sambarino, D. Sankhare, R. Santucci, J. Scholler, R. Selmi, C. Stamm, C. Tanguy, D. Tessier, H. Thery, C. Turci, N. Vantard, N. Vauvarin, D. Viard, C. Vignand, C. Villa, P. Vonna, S. Wacker, N. Wereszczynski, L. Zerhouni
Publikováno v: BMJ Open, Vol 11, Iss 10 (2021)
Objectives Computerised physician order entry (CPOE) systems facilitate the review of medication orders by pharmacists. Reports have emerged that show conception flaws or the misuse of CPOE systems generate prescribing errors. We aimed to characteris
Externí odkaz: https://doaj.org/article/67a8eaf647b34096984ba0488f12634a
Zobrazit plný text záznamu
3
Development of clinical pharmacy programs integrated into patient care pathways using adverse event risks
Autor: Claude Dussart, A. Janoly-Dumenil, X. Dode, V. Bréant, Sylvain Goutelle, C. Pivot, Christine Pivot, Marine Barral, Catherine Rioufol, Julie Martin, M. Barral, D. Hoegy, I. Carpentier, Delphine Hoegy, J. Martin, Audrey Janoly-Dumenil, E. Delande, Evariste Delande, C. Mouchoux, Christelle Mouchoux, Laurent Bourguignon, B. Mandy, F. Ranchon, M. Bolon-Larger, Florence Ranchon, M. Aussedat
Publikováno v: Research in Social and Administrative Pharmacy. 18:3052-3057
Background In the strained actual economic context, all clinical pharmacy activities cannot be achieved for all patients of all care pathways. So finding a way to prioritize moments and patients needing those activities is essential. This is the chal
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ca7535fe754d39fafc5182751a8f15c
https://doi.org/10.1016/j.sapharm.2021.08.005
Zobrazit plný text záznamu
5
Real-life drug–drug and herb–drug interactions in outpatients taking oral anticancer drugs: comparison with databases
Autor: C. Rioufol, V Schwiertz, A Baudouin, H Prely, C Herledan, V Larbre, A G Caffin, M Maire, N Vantard, F. Ranchon
Publikováno v: Journal of Cancer Research and Clinical Oncology. 148:707-718
Due to polypharmacy and the rising popularity of complementary and alternative medicines (CAM), oncology patients are particularly at risk of drug–drug interactions (DDI) or herb–drug interactions (HDI). The aims of this study were to assess DDI
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::20077bd8c41443a628202ea0f696c181
https://doi.org/10.1007/s00432-021-03645-z
Zobrazit plný text záznamu
8
Thromboembolic events and thromboprophylaxis associated with immunomodulators in multiple myeloma patients: a real-life study
Autor: V, Leclerc, L, Karlin, C, Herledan, L, Marchal, A, Baudouin, A, Gouraud, A G, Caffin, V, Larbre, A, Lazareth, E, Bachy, G, Salles, H, Ghesquières, C, Rioufol, F, Ranchon
Publikováno v: Journal of cancer research and clinical oncology. 148(4)
The aim of this study is to assess international guidelines implementation concerning thromboprophylaxis strategy in myeloma patients treated with immunomodulatory drugs.This retrospective study includes multiple myeloma patients treated with immunom
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::730f9ba9467a0b13f606f0b6a1061a4c
https://pubmed.ncbi.nlm.nih.gov/34143239
Zobrazit plný text záznamu
9
Real-life drug-drug and herb-drug interactions in outpatients taking oral anticancer drugs: comparison with databases
Autor: H, Prely, C, Herledan, A G, Caffin, A, Baudouin, V, Larbre, M, Maire, V, Schwiertz, N, Vantard, F, Ranchon, C, Rioufol
Publikováno v: Journal of cancer research and clinical oncology. 148(3)
Due to polypharmacy and the rising popularity of complementary and alternative medicines (CAM), oncology patients are particularly at risk of drug-drug interactions (DDI) or herb-drug interactions (HDI). The aims of this study were to assess DDI and
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::42ccb50c3f4917f8f7a99b9c12c4344b
https://pubmed.ncbi.nlm.nih.gov/33914124
Zobrazit plný text záznamu
10
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje